Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 8/20 | 0.51 |
| ▸ | BRD4 | O60885 | 6/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 2/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.37 |
| ▸ | PRLHR | P49683 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2447273 | 0.89 | CREBBP (0.53) | CREBBPBRD4GSK3BDYRK1ASYK | |
| SCHEMBL2450016 | 0.87 | CREBBP (0.49) | CREBBPBRD4SYKGPR119PRLHR | |
| SCHEMBL2446677 | 0.86 | GSK3B (0.36) | CREBBPBRD4GSK3BDYRK1ASYK | |
| SCHEMBL2847158 | 0.83 | CREBBP (0.51) | CREBBPBRD4GSK3BDYRK1ASYK | |
| SCHEMBL2451064 | 0.81 | CREBBP (0.56) | CREBBPBRD4SYK | |
| SCHEMBL2447343 | 0.81 | CREBBP (0.51) | CREBBPBRD4SYK | |
| SCHEMBL2450613 | 0.81 | CREBBP (0.51) | CREBBPBRD4PRLHR | |
| SCHEMBL2449067 | 0.81 | CREBBP (0.61) | CREBBPBRD4SYK | |
| SCHEMBL2449938 | 0.81 | CREBBP (0.50) | CREBBPBRD4PRLHR | |
| SCHEMBL2449770 | 0.80 | CREBBP (0.49) | CREBBPBRD4GPR119PRLHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367826-A1 | MODULATORS OF AMYLOID BETA. | AstraZeneca AB (SE) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010053438-A1 | MODULATORS OF AMYLOID BETA. | ASTRAZENECA AB (SE) | 2010-05-14 | — | — | WO | disclosed |